Vyome (HIND) Stock: Buy, Sell, or Hold?
HIND - Vyome Holdings, Inc. Common Stock
$1.84
-0.03 (-1.60%)
▼
5d:
-8.46%
30d:
-12.38%
90d:
-15.6%
WAIT
LOW Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Nov 13, 2026
24d
Get Alerted When HIND Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HIND shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HIND shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: HIND is currently trading at $1.84, which is considered oversold relative to its 30-day fair value range of $1.92 to $2.06.
Technical Outlook: Technically, HIND is in a downtrend. The price is currently testing key support at $1.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.83 (+380.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HIND is in a downtrend. The price is currently testing key support at $1.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.83 (+380.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.92 -
$2.06
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 380.1% below Wall St target ($8.83)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.92 -
$2.06
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.83
Resistance Level
$2.09
Current Trend
Downtrend
Technical data as of
Oct 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.31
Wall Street Target
$8.83
(+380.1%)
Revenue Growth (YoY)
-46.0%
Share & Embed Analysis
Last updated: October 19, 2026 5:24 PM ET
Data refreshes hourly during market hours. Next update: 6:24 PM
Data refreshes hourly during market hours. Next update: 6:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HIND showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 54 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 58 HOLD |
|
FDMT
4D Molecular Therapeutic… |
STRONG BUY
12 analysts |
$28 | 62 BUY |